Tweet
In 2010, a single vaccine for seasonal influenza and A-H1N1
Director of Birmex estimated circulation of the new virus could be 3 years.
Mon, 30/11/2009 - 05:58
For next year, only require a squad to be protected against four influenza viruses, including the A-H1N1. NtxGuadalajara .- For the coming 2010-2011 winter vaccine-H1N1 influenza A will be included in the same dose of influenza vaccine called "seasonal", and hence its coverage is extended to all groups that already receive this last, said deputy general director of Control and Quality Assurance of Biologics and Reagents Mexico (Birmex), Jos? Luis Valdespino G?mez.
"The World Health Organization [WHO] has taken the decision to incorporate the A-H1N1 vaccine for seasonal," said the federal official interviewed by the Public as part of the International Book Fair of Guadalajara (FIL), which is held in this city where he gave a presentation on the future of vaccination in Latin America.
Valdespino Gomez explained that the seasonal influenza vaccine has in turn two other influenza viruses, A-H3N2 and B, and was incorporated into the A-H1N1 to protect people with a single dose, which will be available from next northern hemisphere winter "that is, from September, October 2010 to March" 2011; hemisphere to which it belongs Mexico.
After ensuring that this country, through Birmex, would be able to produce the vaccine against influenza A-H1N1, which "depends on time and money," explained that there is an option now covered by the incorporation of biological to the same vaccine and because "these viruses (influenza pandemics) not significantly circulating last beyond three years."
He added, however, that vaccination against the A-H1N1 should be extended for two to three years (a total of six) as a precaution.
The federal official said the strategy of vaccination that is now Mexico is adequate. Asked about the evolution of the pandemic in our country, where currently 65.099 confirmed cases of A-H1N1 and 610 deaths, according to the report of 25 November the Ministry of Health, joked: "My grandmother was Chinese and said that the best prediction was not made. "
He acknowledged that the "Influenza is a virus that has no word, constantly mutates, if only the A-H1N1 see no problem, the trouble is that a virus appeared more capable of virulence such as Southeast Asia waiting the avian influenza. Who can predict it, nobody in their right mind. "
In 2009, Birmex produced 50 million doses of seasonal influenza vaccines and about 80 million vaccines for polio, the latter distributed throughout the country during the national health weeks, for the implementation and reinforcement of children under six years, he said.
With regard to biological polio. "We have to buy vaccines from any country, here the produce," he said, after announcing that in Mexico we are initiating efforts to sell to other countries. " The polio vaccine would be the first to export the nation.
He acknowledged that because of the epidemiological transition the region faces new diseases and the resurgence while other "such as influenza viruses are constantly mutating.
Given this scenario, "obviously we vaccines are a panacea, and not all diseases can be prevented or cured by vaccines," he said, although this area has high expectations that are not infectious diseases. "In diabetes mellitus and Alzheimer's vaccines are working ... we will move us from one stage of a preventive vaccine to a phase of therapeutic vaccines," he said.
The scheme
The universal immunization schedule consists of fourteen Mexican vaccines, fifteen U.S.
The older vaccine is BCG, TB
The latest scheme was included in that of rotavirus in 2007
In 1973 the Mexican scheme had six shots at a cost of 2.5 dollars per child
In 2009 is fourteen shots at a cost of $ 196 per child
Mexico acquired 30 million doses of influenza A-H1N1, which are enforced in the coming months
The only disease that mankind has been able to eliminate their direct involvement is smallpox, it was with a vaccine
Mexico's goal is to keep polio eradicated in a short time and eradicate measles
The immediate challenge is the inclusion of the vaccine against human papillomavirus (HPV) to free universal coverage scheme for all girls, which would prevent the death of thousands of women for cervical cancer
Include the HPV vaccine would raise a $ 301 investment in the universal scheme for every child
Faced with insufficient resources to the proposal of the study presented is the gradual incorporation of the biologicals to reach universal coverage free
Maricarmen Rello